Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $23.5 million.

  • Pyxis Oncology's Operating Expenses fell 123.35% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year change of. This contributed to the annual value of $105.6 million for FY2024, which is 2848.07% up from last year.
  • As of Q3 2025, Pyxis Oncology's Operating Expenses stood at $23.5 million, which was down 123.35% from $22.6 million recorded in Q2 2025.
  • Pyxis Oncology's Operating Expenses' 5-year high stood at $40.1 million during Q4 2024, with a 5-year trough of $20.0 million in Q2 2024.